Viracta Therapeutics to Present at Upcoming Investor Conferences
Viracta Therapeutics (NASDAQ: VIRX) is set to present at multiple investor conferences in November 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viracta Therapeutics (NASDAQ: VIRX) is set to present at multiple investor conferences in November 2021. Key events include:
- Credit Suisse 30th Annual Healthcare Conference: Nov 8-12, Presentation on Nov 11 at 1:50 PM ET.
- Jefferies London Healthcare Conference: Nov 16-17, Presentation on Nov 17 at 10:40 AM GMT.
- Piper Sandler 33rd Annual Healthcare Conference: Nov 29-Dec 2, Presentation on Nov 22.
- Evercore ISI 4th Annual HealthCONx Conference: Nov 29-Dec 2, Presentation on Dec 2 at 3:55 PM ET.
Webcasts will be available on their website.
Details
News Market Reaction – VIRX
The recorded move for VIRX in the trading session of this news was -2.36%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Nov. 1, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that company management is scheduled to present and host one-on-one meetings at the following upcoming investor conferences:
Credit Suisse 30th Annual Healthcare Conference (virtual) | ||
Conference Dates: | November 8 – 12, 2021 | |
Presentation Date: | November 11, 2021 | |
Presentation Time: | 1:50 PM ET | |
Format: | Corporate presentation | |
Jefferies London Healthcare Conference (in-person) | ||
Conference Dates: | November 16 – 17, 2021 | |
Presentation Date: | November 17, 2021 | |
Presentation Time: | 10:40 AM GMT/ 5:40 AM ET | |
Format: | Corporate presentation | |
Piper Sandler 33rd Annual Healthcare Conference (virtual) | |
Conference Dates: | November 29 – December 2, 2021 |
Presentation Available: | November 22, 2021, at 10:00 AM ET |
Format: | Corporate presentation |
Evercore ISI 4th Annual HealthCONx Conference (virtual) | |||
Conference Dates: | November 29 – December 2, 2021 | ||
Presentation Date: | December 2, 2021 | ||
Presentation Time: | 3:55 PM ET | ||
Format: | Fireside chat | ||
A live webcast of each of the presentations will be available under "Events and Webcasts" in the Investors section of the Viracta website at https://viracta.investorroom.com/events-and-webcasts. Replays of each webcast will be archived on the Viracta website for at least 30 days following the presentation.
About Viracta Therapeutics, Inc.
Viracta is a precision oncology company targeting virus-associated malignancies. Viracta's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in two Phase 2 clinical trials for EBV-positive (EBV+) lymphoma and one Phase 1b/2 trial in patients with EBV+ nasopharyngeal carcinoma and other EBV+ solid tumors. Viracta is also pursuing the application of its inducible synthetic lethality approach in other virus-related cancers. For additional information please visit www.viracta.com.
Investor Relations Contact:
Ashleigh Barreto
Head of Investor Relations and Corporate Communications
Viracta Therapeutics, Inc.
abarreto@viracta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/viracta-therapeutics-to-present-at-upcoming-investor-conferences-301413256.html
SOURCE Viracta
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.